Global Stock News

Did Amphastar Pharmaceuticals’ (NASDAQ:AMPH) Share Price Deserve to Gain 31%?

Article feature image

Did Amphastar Pharmaceuticals’ (NASDAQ:AMPH) Share Price Deserve to Gain 31%?

When you buy and hold a stock for the long term, you definitely want it to provide a positive return. Furthermore, you’d generally like to see the share price rise faster than the market But Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) has fallen short…

Click here to view the original article.

Share this article

Scroll to Top